Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study
Objective To evaluate the clinical and microbiological efficacy and safety of three doses of 3 g fosfomycin tromethamine administered orally to treat lower urinary tract infections.Design and participants This prospective, uncontrolled, open-label study was conducted in 12 medical centres in China,...
Saved in:
Main Authors: | Shan Chen, Yong Yang, Bo Yang, Ming Chen, Kai Zhang, Yi Wang, Lu-Dong Qiao, Bo Zheng, Hong-Feng Guo, Yuan-Jie Niu, Ben-Kang Shi, Wei-Min Yang, Xiao-Kun Zhao, Xiao-Feng Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2013-12-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/3/12/e004157.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors and prediction model construction of urinary tract infection in elderly patients with diabetic nephropathy
by: Cong Feng, et al.
Published: (2025-01-01) -
The Detection of Fosfomycin-Modifying Enzymes (fos) in Uropathogenic Enterobacterale, Azerbaijan, Iran
by: Aidin Lalezadeh, et al.
Published: (2023-01-01) -
Investigation of the Effects of Fosfomycin in Kidney Damage Caused by CLP-Induced Sepsis
by: Ilknur Esen Yildiz, et al.
Published: (2024-12-01) -
Pegloticase and Methotrexate Cotherapy in Patients With Uncontrolled Gout With Prior Pegloticase Monotherapy Failure: Findings of an Open‐Label Trial
by: Orrin M. Troum, et al.
Published: (2025-01-01) -
Urinary Tract Infections in Adults
by: Evan B. Cohn, et al.
Published: (2004-01-01)